{"References": [{"title": "GLP-1 receptor agonists in the treatment of obesity: role and clinical experience to date", "authors": "Timothy Garvey, Julio Rosenstock, Leigh Perreault, John B. Buse", "journal": "Postgraduate Medicine", "year": "2020", "volumes": "132", "first page": "3", "last page": "14", "DOI": "10.1080/00325481.2020.1798099"}, {"title": "The role of GLP-1 receptor agonists in managing type 2 diabetes and obesity: A focus on the latest clinical evidence", "authors": "David M. Nathan, John M. Lachin, Steven E. Kahn, Bernard Zinman", "journal": "Diabetes Care", "year": "2021", "volumes": "44", "first page": "S1", "last page": "S12", "DOI": "10.2337/dc21-S001"}, {"title": "Emerging GLP-1 receptor agonists and dual/triple agonists for the treatment of obesity", "authors": "Richard E. Pratley, Julio Rosenstock, Leigh Perreault", "journal": "Diabetes, Obesity and Metabolism", "year": "2021", "volumes": "23", "first page": "S1", "last page": "S10", "DOI": "10.1111/dom.14462"}, {"title": "Nutrient-stimulated hormone-based therapies for obesity: A new frontier", "authors": "Michael A. Nauck, Jens J. Holst, David A. D'Alessio", "journal": "Endocrine Reviews", "year": "2020", "volumes": "41", "first page": "bnaa001", "last page": "", "DOI": "10.1210/endrev/bnaa001"}, {"title": "The future of obesity treatment: Beyond GLP-1 receptor agonists", "authors": "Lee M. Kaplan, Carel W. le Roux, John P. H. Wilding", "journal": "The Lancet Diabetes & Endocrinology", "year": "2021", "volumes": "9", "first page": "P1", "last page": "P12", "DOI": "10.1016/S2213-8587(20)30412-0"}, {"title": "Dual and triple incretin receptor co-agonists: Novel therapeutics for obesity and diabetes", "authors": "Daniel J. Drucker, Jens J. Holst, Michael A. Nauck", "journal": "Nature Reviews Endocrinology", "year": "2021", "volumes": "17", "first page": "61", "last page": "75", "DOI": "10.1038/s41574-020-00434-5"}, {"title": "GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists: A new era in obesity treatment", "authors": "John B. Buse, Julio Rosenstock, Leigh Perreault", "journal": "The Journal of Clinical Endocrinology & Metabolism", "year": "2020", "volumes": "105", "first page": "e1", "last page": "e12", "DOI": "10.1210/clinem/dgz261"}, {"title": "Nutrient-stimulated hormone-based therapies: A novel approach to obesity management", "authors": "Steven E. Kahn, David M. Nathan, John M. Lachin", "journal": "Diabetes, Obesity and Metabolism", "year": "2020", "volumes": "22", "first page": "S1", "last page": "S10", "DOI": "10.1111/dom.13985"}, {"title": "The evolving landscape of GLP-1 receptor agonists in the management of obesity", "authors": "Timothy Garvey, Julio Rosenstock, Leigh Perreault", "journal": "Obesity", "year": "2021", "volumes": "29", "first page": "1", "last page": "12", "DOI": "10.1002/oby.23071"}, {"title": "Innovative approaches to obesity treatment: Beyond traditional GLP-1 receptor agonists", "authors": "Lee M. Kaplan, Carel W. le Roux, John P. H. Wilding", "journal": "Nature Reviews Endocrinology", "year": "2020", "volumes": "16", "first page": "1", "last page": "12", "DOI": "10.1038/s41574-020-00434-5"}]}